well10 Aug 2021 16:11
InnoMed Tech Ltd is holding Company of medical science companies in the business of creating paradigm shifts in thinking to improve clinical outcomes for medical and surgical patients. The Company’s clinical and business leadership team combines years of experience of corporate, and medical science who along with medical engineers, key advisors, work to solve problems presenting in today’s medical and surgical patient population.
Directors Innomed Tec Ltd. (Parent Co):
Robert L. Rhodes - Australia (CEO)
Terrance A .Larkan - Australia (CFO)
Billy Williams - US
David Toyoda - Canada
Dr Marshall Walker- US
Directors PureFlowCath LLC. (US):
Dr Matthew Mcintyre
Robert L. Rhodes
3 to 2 independant directors
Summary of Operations
Innomed Tech Ltd. is pleased to update you on some corporate actions since our last update on June 30, 2021.
The Company has raised an additional US$350,000 to fund working capital at same terms as previous cash investors. The Company has started to receive equity investment inquiries from professional investors and specialist medical technology funds. Should management decide to inject more funds into the Company, current shareholders will be consulted before any action is taken.
Public Listing Update on the TSX Venture Exchange
The Company prospectus review by the regulator is largely completed. The Company after April 2021 is required to complete audited financial statements to December 31, 2020, and interim financial statement to June 30, 2021. The Company has already completed two years prior. The additional year audit is expected to be completed end of August 2021 and undergoing final audit Partner review by RSM Canada. The Company will then file the update financial statements in the prospectus for final approval and to finalize the listing application on the TSX Venture Exchange.
Appointment of Computershare
The Company has appointed Computershare Investor Service Inc. as its Share Registrar replacing AST. AST has advised that it is being acquired by the TMX which is part of the Toronto Stock Exchange. The Company has chosen to maintain a fully independent registrar necessitating the change. The Company will also use Computershare as filing agent for prospectus filings with regulator and stock exchange.
Board and Management vist to US
CIC Capital Ltd. Stuart J. Bromley, Directors David Toyoda and Robert L. Rhodes (CEO / Executive Director) will travel and meet our shareholders (owners of the Company) personally as soon as COVID-19 travel restrictions in their applicable jurisdictions is lifted.
www.InnomedTec.com
Billy Williams Disclosure Officer/Director +1 251 786 4695 billy@wfgplanning.com
Key service organisations:
Sign In
Follow the stocks
